CV Sciences (CVSI) Cash & Equivalents Growth (5y) (2015 - 2026)
CV Sciences (CVSI) Cash & Equivalents Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -35.91% |
| Mar 31, 2026 | -43.07% |
| Dec 31, 2025 | -41.40% |
| Dec 31, 2024 | -35.29% |
| Dec 31, 2023 | 34.43% |
| Jun 30, 2023 | -23.51% |
| Dec 31, 2022 | -4.74% |
| Sep 30, 2022 | 1.87% |
| Dec 31, 2021 | 5.39% |
| Jun 30, 2021 | 17.15% |
| Mar 31, 2021 | 90.06% |
| Dec 31, 2020 | 50.66% |
| Dec 31, 2019 | 11.68% |
| Dec 31, 2018 | -33.13% |
| Jun 30, 2018 | 142.67% |
| Dec 31, 2017 | 348.14% |
| Sep 30, 2017 | 476.54% |
| Dec 31, 2016 | 290.27% |
| Sep 30, 2016 | 102.88% |
| Jun 30, 2016 | 181.54% |